Unique Epitopes on CεmX in IgE-B Cell Receptors Are Potentially Applicable for Targeting IgE-Committed B Cells
Unique Epitopes on CεmX in IgE-B Cell Receptors Are Potentially Applicable for Targeting IgE-Committed B Cells
复制标题
DOI:
10.4049/jimmunol.0902437
复制
发表时间:
2010-02-15
影响因子:
4.4
通讯作者:
Chang, Tse Wen
中科院分区:
文献类型:
--
作者:
Chen, Jiun-Bo;Wu, Pheidias C.;Chang, Tse Wen
Membrane-bound IgE (mIgE) is part of the IgE-BCR and is essential for generating isotype-specific IgE responses. On mIgE(+) B cells, the membrane-bound epsilon-chain (m epsilon) exists predominantly in the long isoform, m epsilon(L), containing an extra 52 aa C epsilon mX domain between CH4 and the C-terminal membrane-anchoring segment; the short isoform of m epsilon, m epsilon(S), exists in minor proportions. C epsilon mX thus provides an attractive site for immunologic targeting of mIgE(+) B cells. In this study, we show that nine newly prepared C epsilon mX-specific mAbs, as well as the previously reported a20, bound to mIgE.Fc(L)-expressing CHO cells, while only 4B12 and 26H2 bound to mIgE.Fc(L)-expressing B cell line Ramos cells. The mAb 4B12 bound to the N-terminal part, 26112 the middle part, and all others the C-terminal part of C epsilon mX. Expression of Ig alpha and Ig beta on the mIgE.Fc(L)-CHO cells reduces the binding of a20 to C epsilon mX as compared with that of 41312 and 26H2. The chimeric mAbs c4B12 and c26H2, when cross-linked by secondary antibodies, lysed mIgE.Fc(L)-Ramos cells by apoptosis through a BCR-dependent caspase pathway. Using PBMCs as the source of effector cells, c4B12 and c26H2 demonstrated Ab-dependent cellular cytotoxicity toward mIgE.Fc(L)-Ramos cells in a dose-dependent fashion. In cultures of PBMCs from atopic dermatitis patients, c4B12 and c26H2 inhibited the synthesis of IgE driven by anti-CD40 and IL-4. These results suggest that 41312 and 26H2 and an immunogen using the peptide segments recognized by these mAbs are potentially useful for targeting mIgE(+) B cells to control IgE production. The Journal of Immunology, 2010, 184: 1748-1756.